Head and Neck Cancer

A Randomized, Double-Blind Placebo-Controlled, Phase 3 Study of Debio 1143 in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck,...

Lilly JVBA

A Randomized, Double-Blind, Phase 3 Study of Docetaxel and Ramucirumab vs Docetaxel and Placebo in Treatment of Stage IV Non-Small Cell Lung Cancer Following Disease Progression After One Prior Platinum-Based Therapy.

Wyeth 3004

A Randomized, Double-Blind, Placebo-Controlled Trial of Neratinib (HKI-272) After Trastuzumab in Women with Early-Stage HER-2/Neu Overexpressed/Amplified Breast Cancer.

GSK Magrit

A Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trial to Assess the Efficacy of recMAGE-A3 + AS15 Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients with MAGE-A3 Positive Non-Small Cell Lung Cancer.

GTx G300504

Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effect of Gtx-024 on Muscle Wasting in Patients with Non-Small Cell Lung Cancer on First-Line Platinum Plus a Taxane Chemotherapy.